Types of chemotherapy
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Types of Chemotherapy: An Overview
Platinum-Based Chemotherapy
Platinum vs. Non-Platinum Chemotherapy
Platinum-based chemotherapy has been shown to be more effective than non-platinum therapies in treating various cancers, including advanced ovarian cancer and non-small cell lung cancer (NSCLC) . Studies indicate that both cisplatin and carboplatin, two common platinum compounds, offer similar efficacy in terms of survival benefits and quality of life improvements .
Single-Agent vs. Combination Therapy
Combination therapies involving platinum compounds tend to be more effective than single-agent treatments. For instance, in advanced ovarian cancer, platinum combinations have shown a trend towards better outcomes compared to single-agent platinum therapies. Similarly, in NSCLC, combining newer agents like gemcitabine, paclitaxel, irinotecan, and vinorelbine with cisplatin has provided additional survival benefits.
Cytotoxic Chemotherapy
Metastatic Breast Cancer
Cytotoxic chemotherapy remains a cornerstone in the treatment of metastatic breast cancer (MBC). Common agents include anthracyclines, taxanes, capecitabine, eribulin, and ixabepilone, either as single agents or in combination. Newer agents like etirinotecan pegol are also being evaluated for their efficacy in MBC.
Colorectal Cancer
In colorectal cancer, adjuvant chemotherapy with fluorouracil and leucovorin has shown significant improvements in disease-free and overall survival, particularly in stage Dukes' C colon cancer. High-dose infusional regimens with modulated fluorouracil may offer better outcomes compared to conventional bolus regimens.
Adjuvant and Neoadjuvant Chemotherapy
Adjuvant Chemotherapy
Adjuvant chemotherapy, administered after primary treatments like surgery, has been effective in increasing long-term survival rates in various cancers. For example, in breast cancer, adjuvant chemotherapy has significantly reduced recurrence rates. In rectal cancer, postoperative adjuvant chemotherapy with 5-fluorouracil has shown a significant reduction in the risk of death and disease recurrence.
Neoadjuvant Chemotherapy
Neoadjuvant chemotherapy, given before primary treatments, is also gaining traction. In stage IIIAN2 NSCLC, induction chemotherapy followed by surgery has shown significant survival advantages. This approach is also being explored in other cancers to improve surgical outcomes and long-term survival.
High-Dose Chemotherapy and Stem Cell Support
High-dose chemotherapy followed by autologous or allogeneic stem cell transplantation is another strategy used in certain cancers like indolent non-Hodgkin's lymphoma and advanced ovarian cancer. While high response rates are achieved, the duration of response is often short, and such treatments are generally recommended within controlled clinical trials .
Targeted and Novel Chemotherapeutic Agents
New Cytotoxic Agents
New cytotoxic agents are continually being developed to target specific cancer pathways. For instance, oxaliplatin and irinotecan have shown promise in colorectal cancer, improving response rates and survival when added to existing regimens. Similarly, novel agents like etirinotecan pegol are being evaluated for their efficacy in MBC.
Molecular and Cellular Biology
Advancements in molecular and cellular biology are paving the way for more targeted chemotherapeutic approaches. These new strategies aim to improve the efficacy and reduce the toxicity of traditional chemotherapy.
Conclusion
Chemotherapy remains a vital component in the treatment of various cancers, with ongoing research continually refining and improving its efficacy. From platinum-based therapies to novel cytotoxic agents, the landscape of chemotherapy is ever-evolving, offering hope for better outcomes and improved quality of life for cancer patients.
Sources and full results
Most relevant research papers on this topic